A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about managing side effects following prostate cancer treatment. While treatment ...

Men with advanced prostate cancer undergoing local therapies such as radiation therapy or radical prostatectomy experience significantly more gastrointestinal and sexual issues, along with problems ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Discover how rectal spacers revolutionize prostate cancer treatment by reducing side effects and enhancing radiation dose ...

A week after an announcement made by Biden's office about former US President's undergoing medical care, Joe Biden rang a ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...